News

Filter

Current filters:

Merck KGaAVaccines

1 to 9 of 25 results

News briefs from Threshold, Merck KGaA and GSK

18-09-2012

US biotech firm Threshold Pharmaceuticals (Nasdaq: THLD) said yesterday that data from a Phase IIb trial…

BiotechnologyErbituxEuropeGlaxoSmithKlineMerck KGaAMerck SeronoOncologyPharmaceuticalRegulationResearchSynflorixTH-302Threshold PharmaceuticalsVaccines

Ark Therapeutics signs a letter of intent with Merck KGaA unit

16-08-2012

UK-based Ark Therapeutics (LON: AKT) shares rose nearly 6.5% on the back of the good news that it has…

Ark TherapeuticsMerck KGaAMilliporePharmaceuticalProductionResearchVaccines

Merck KGaA pleased with Millipore buy, plans resubmission for cladribine and updates on Stimuvax

12-04-2010

Speaking at the company’s annual general meeting Karl-Ludwig Kley, chairman of the executive board…

CladribineFinancialMerck KGaAMetabolicsNeurologicalPharmaceuticalResearchStimuvaxVaccines

Merck KGaA temporarily suspends cancer vaccine Stimuvax clinical program due to case of encephalitis

23-03-2010

Merck Serono, a division of German drug major Merck KGaA, and its US affiliate, EMD Serono, have temporarily…

Merck KGaAOncologyPharmaceuticalRegulationResearchStimuvaxVaccines

1 to 9 of 25 results

COMPANY SPOTLIGHT

Menarini

Back to top